Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma

This study has been completed.
Royal Adelaide Hospital
Trident Clinical Research Pty Ltd
Information provided by (Responsible Party):
Lipotek Pty Ltd Identifier:
First received: January 18, 2010
Last updated: April 10, 2012
Last verified: April 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)